Canopy Growth Corporation Common Shares (CGC) is a publicly traded Healthcare sector company. As of May 21, 2026, CGC trades at $1.03 with a market cap of $415.34M and a P/E ratio of -0.55. CGC moved +4.57% today. Year to date, CGC is -13.45%; over the trailing twelve months it is -41.81%. Its 52-week range spans $0.77 to $5.80. Analyst consensus is buy with an average price target of $1.24. Rallies surfaces CGC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CGC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CGC recently traded at $1.03. Market cap is $415.34M. P/E ratio is -0.55. Revenue is $278.39M.
| Metric | Value |
|---|---|
| Price | $1.03 |
| Market Cap | $415.34M |
| P/E Ratio | -0.55 |
| EPS | $-1.88 |
| Dividend Yield | 0.24% |
| 52-Week High | $5.80 |
| 52-Week Low | $0.77 |
| Volume | 6.63K |
| Avg Volume | 0 |
| Revenue (TTM) | $278.39M |
| Net Income | $-326.58M |
| Gross Margin | 25.85% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $269.00M | $-598.12M | $-5.56 |
| 2024 | $297.15M | $-675.79M | $-8.79 |
| 2023 | $402.90M | $-3.31B | $-7.07 |
| 2022 | $520.33M | $-320.49M | $0.00 |
3 analysts cover CGC: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.24.